EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Oral repaglinide versus insulin injection in type II diabetes mellitus; a randomized clinical trial

Hosein Chiti, Maryam Hajipour Manjili, Aiyoub Pezeshgi, Seyednouraddin Mousavinasab, Zahra Abbaspour, Masoud Asadi-Khiavi

Journal of Nephropharmacology · 2017

DOI: 10.15171/npj.2017.25 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Nephropharmacology, 2017. Verfasst von Hosein Chiti und 5 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Chiti, H., Manjili, M. H., Pezeshgi, A., Mousavinasab, S., Abbaspour, Z., & Asadi-Khiavi, M. (2017). Oral repaglinide versus insulin injection in type II diabetes mellitus; a randomized clinical trial. Journal of Nephropharmacology. https://doi.org/10.15171/npj.2017.25

Vancouver

Chiti H, Manjili MH, Pezeshgi A, Mousavinasab S, Abbaspour Z, Asadi-Khiavi M. Oral repaglinide versus insulin injection in type II diabetes mellitus; a randomized clinical trial. Journal of Nephropharmacology. 2017. doi:10.15171/npj.2017.25

BibTeX
@article{Chiti2017,
  author = {Chiti, Hosein and Manjili, Maryam Hajipour and Pezeshgi, Aiyoub and Mousavinasab, Seyednouraddin and Abbaspour, Zahra and Asadi-Khiavi, Masoud},
  title = {Oral repaglinide versus insulin injection in type II diabetes mellitus; a randomized clinical trial},
  journal = {Journal of Nephropharmacology},
  year = {2017},
  doi = {10.15171/npj.2017.25}
}
Kostenlos starten →